BOSTON -- (BUSINESS WIRE) -- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that it will present at the Morgan Stanley Global Healthcare Conference on Wednesday, September 10 at 8:35 a.m. ET.
Management’s remarks can be accessed live through Vertex’s website at www.vrtx.com in the “Investors” section under the “Events and Presentations” link. To ensure a timely connection, it is recommended that users register at least 10 minutes prior to the scheduled webcast. A replay of the webcast will also be archived on the company’s website for a period of two weeks following the presentation.
Vertex is a global biotechnology company that aims to discover, develop and commercialize innovative medicines so people with serious diseases can lead better lives. In addition to our clinical development programs focused on cystic fibrosis, Vertex has more than a dozen ongoing research programs aimed at other serious and life-threatening diseases.
Founded in 1989 in Cambridge, Mass., Vertex today has research and development sites and commercial offices in the United States, Europe, Canada and Australia. For four years in a row, Science magazine has named Vertex one of its Top Employers in the life sciences. For additional information and the latest updates from the company, please visit www.vrtx.com.
Source: Vertex Pharmaceuticals Incorporated